Adjuvant therapy of breast cancer

Nancy E. Davidson, Martin D. Abeloff

Research output: Contribution to journalArticle

Abstract

About 180,000 American women will be diagnosed with early stage breast cancer during 1993. In many of these patients breast cancer is a systemic disease at diagnosis and thus not curable by local treatment alone. The development of optimal forms of systemic adjuvant therapy has been a major area of research for more than 30 years. The two most widely employed types of adjuvant therapy, cytotoxic chemotherapy and tamoxifen, have been shown to improve relapse-free and overall survival in certain patient subsets. This review highlights recent advances in adjuvant therapy of early stage breast cancer and discusses current treatment guidelines.

Original languageEnglish (US)
Pages (from-to)112-116
Number of pages5
JournalWorld journal of surgery
Volume18
Issue number1
DOIs
StatePublished - Jan 1 1994

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Adjuvant therapy of breast cancer'. Together they form a unique fingerprint.

  • Cite this

    Davidson, N. E., & Abeloff, M. D. (1994). Adjuvant therapy of breast cancer. World journal of surgery, 18(1), 112-116. https://doi.org/10.1007/BF00348200